Literature DB >> 24451374

Vaccinia viral protein A27 is anchored to the viral membrane via a cooperative interaction with viral membrane protein A17.

Da-Rong Wang1, Jye-Chian Hsiao, Chien-Hsuan Wong, Guo-Chian Li, Su-Ching Lin, Steve S-F Yu, Wenlung Chen, Wen Chang, Der-Lii M Tzou.   

Abstract

The vaccinia viral protein A27 in mature viruses specifically interacts with heparan sulfate for cell surface attachment. In addition, A27 associates with the viral membrane protein A17 to anchor to the viral membrane; however, the specific interaction between A27 and A17 remains largely unclear. To uncover the active binding sites and the underlying binding mechanism, we expressed and purified the N-terminal (18-50 residues) and C-terminal (162-203 residues) fragments of A17, which are denoted A17-N and A17-C. Through surface plasmon resonance, the binding affinity of A27/A17-N (KA = 3.40 × 10(8) m(-1)) was determined to be approximately 3 orders of magnitude stronger than that of A27/A17-C (KA = 3.40 × 10(5) m(-1)), indicating that A27 prefers to interact with A17-N rather than A17-C. Despite the disordered nature of A17-N, the A27-A17 interaction is mediated by a specific and cooperative binding mechanism that includes two active binding sites, namely (32)SFMPK(36) (denoted as F1 binding) and (20)LDKDLFTEEQ(29) (F2). Further analysis showed that F1 has stronger binding affinity and is more resistant to acidic conditions than is F2. Furthermore, A27 mutant proteins that retained partial activity to interact with the F1 and F2 sites of the A17 protein were packaged into mature virus particles at a reduced level, demonstrating that the F1/F2 interaction plays a critical role in vivo. Using these results in combination with site-directed mutagenesis data, we established a computer model to explain the specific A27-A17 binding mechanism.

Entities:  

Keywords:  Pox Viruses; Protein Structure; Protein-Protein Interactions; Viral Protein; Virus Assembly

Mesh:

Substances:

Year:  2014        PMID: 24451374      PMCID: PMC3945326          DOI: 10.1074/jbc.M114.547372

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Regulation of vaccinia virus morphogenesis: phosphorylation of the A14L and A17L membrane proteins and C-terminal truncation of the A17L protein are dependent on the F10L kinase.

Authors:  T Betakova; E J Wolffe; B Moss
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 2.  Poxvirus entry and membrane fusion.

Authors:  Bernard Moss
Journal:  Virology       Date:  2006-01-05       Impact factor: 3.616

Review 3.  NMR methods for the study of protein structure and dynamics.

Authors:  L E Kay
Journal:  Biochem Cell Biol       Date:  1997       Impact factor: 3.626

4.  Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid rafts.

Authors:  Che-Sheng Chung; Cheng-Yen Huang; Wen Chang
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Tyrosine phosphorylation of A17 during vaccinia virus infection: involvement of the H1 phosphatase and the F10 kinase.

Authors:  M Derrien; A Punjabi; M Khanna; O Grubisha; P Traktman
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

6.  A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate.

Authors:  C S Chung; J C Hsiao; Y S Chang; W Chang
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells.

Authors:  J C Hsiao; C S Chung; W Chang
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

8.  The oligomeric structure of vaccinia viral envelope protein A27L is essential for binding to heparin and heparan sulfates on cell surfaces: a structural and functional approach using site-specific mutagenesis.

Authors:  Yu Ho; Jye-Chian Hsiao; Min-Hsiang Yang; Che-Sheng Chung; Yu-Chang Peng; Ta-Hsien Lin; Wen Chang; Der-Lii M Tzou
Journal:  J Mol Biol       Date:  2005-06-24       Impact factor: 5.469

9.  Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles.

Authors:  Che-Sheng Chung; Chein-Hung Chen; Ming-Yi Ho; Cheng-Yen Huang; Chung-Lin Liao; Wen Chang
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

10.  The vaccinia virus 14-kilodalton (A27L) fusion protein forms a triple coiled-coil structure and interacts with the 21-kilodalton (A17L) virus membrane protein through a C-terminal alpha-helix.

Authors:  M I Vázquez; G Rivas; D Cregut; L Serrano; M Esteban
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  5 in total

1.  Inactivation of Genes by Frameshift Mutations Provides Rapid Adaptation of an Attenuated Vaccinia Virus.

Authors:  Tatiana G Senkevich; Erik K Zhivkoplias; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

2.  Structural basis for the inhibition of poxvirus assembly by the antibiotic rifampicin.

Authors:  Damià Garriga; Stephen Headey; Cathy Accurso; Menachem Gunzburg; Martin Scanlon; Fasséli Coulibaly
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-01       Impact factor: 11.205

3.  Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.

Authors:  Thomas Kaever; Michael H Matho; Xiangzhi Meng; Lindsay Crickard; Andrew Schlossman; Yan Xiang; Shane Crotty; Bjoern Peters; Dirk M Zajonc
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

4.  The Vaccinia virion: Filling the gap between atomic and ultrastructure.

Authors:  Yeva Mirzakhanyan; Paul Gershon
Journal:  PLoS Pathog       Date:  2019-01-07       Impact factor: 6.823

5.  Species-Specific Conservation of Linear Antigenic Sites on Vaccinia Virus A27 Protein Homologs of Orthopoxviruses.

Authors:  Henrike P Ahsendorf; Li L Gan; Kamal H Eltom; Ahmed Abd El Wahed; Sven-Kevin Hotop; Rachel L Roper; Ulrike Beutling; Mark Broenstrup; Christiane Stahl-Hennig; Ludwig E Hoelzle; Claus-Peter Czerny
Journal:  Viruses       Date:  2019-05-29       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.